Recruiting OBSERVATIONAL NCT06849193
Dynamic Prediction Model for Patients with Unresectable Biliary Malignancies Receiving Systemic Chemotherapy Combined with Immunotherapy: a Multicenter, Observational Study (BTCICTY-001)
Sponsor: Eastern Hepatobiliary Surgery Hospital
Interventions
Systemic chemotherapy combined with immunotherapy
Updated 1 time since 2025 Last updated: Feb 23, 2025 Started: Jan 31, 2025 Primary completion: Mar 31, 2026 Completion: May 31, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
A observational or N/A phase clinical study on Dynamic Prediction Model and Immunotherapy, this trial is actively recruiting participants. The trial is conducted by Eastern Hepatobiliary Surgery Hospital and has accumulated 1 data snapshot since 2025. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
1 version recorded Recruiting
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Eastern Hepatobiliary Surgery Hospital
- Jiangsu Cancer Institute & Hospital
- Shanghai Zhongshan Hospital
- The First Affiliated Hospital of Zhengzhou University
- The First Affiliated Hospital, University of Science and Technology of China
- The Third Affiliated Hospital of Soochow University
- Yunnan Cancer Hospital
- Zhejiang Cancer Hospital
- Zhongda Hospital
Data source: Zhongda Hospital
For direct contact, visit the study record on ClinicalTrials.gov .